NDC 63459-548-04 - FENTORA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63459-548
- Requested NDC
- 63459-548-04
- Package NDCs from labels
- 63459-548-04, 63459-548-28
- Manufacturer
- Cephalon, LLC
- Effective date
- 2023-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| FENTORA - Cephalon, LLC | Cephalon, LLC | 2023-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63459-548-04 | EA - Each | 63459-548 | 1888c9d2-5870-40eb-9882-5bfa40662b22 | 1 | 2012-07-24 |
| 63459-548-28 | EA - Each | 63459-548 | 5e01f3ae-f449-4a7f-a09f-50ab662fd4de | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | FENTORA (FENTANYL CITRATE) TABLET [CEPHALON, INC.] | 10 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTORA (FENTANYL CITRATE) TABLET [CEPHALON, INC.] | 10 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | FENTORA (FENTANYL CITRATE) TABLET [CEPHALON, INC.] | 10 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | FENTORA (FENTANYL CITRATE) TABLET [CEPHALON, INC.] | 10 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | FENTORA (FENTANYL CITRATE) TABLET [CEPHALON, INC.] | 10 | |
| SODIUM BICARBONATE | INACTIVE INGREDIENT | 8MDF5V39QO | FENTORA (FENTANYL CITRATE) TABLET [CEPHALON, INC.] | 10 | |
| SODIUM CARBONATE | INACTIVE INGREDIENT | 45P3261C7T | FENTORA (FENTANYL CITRATE) TABLET [CEPHALON, INC.] | 10 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | FENTORA (FENTANYL CITRATE) TABLET [CEPHALON, INC.] | 10 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Equate Effervescent Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Walmart | 6271b34b-55a0-40a8-e053-2a91aa0acb22 | 2025-10-17 | Warnings, Adverse reactions | XF417D3PSL 8MDF5V39QO |
| EQUATE SALINE PACKETS | NASAL CLEANING SALT | WALMART INC | 9e905ecb-d4d5-514a-e053-2a95a90adfbb | 2025-10-08 | Warnings | 8MDF5V39QO |
| EQUATE NETI POT SINUS WASH | NASAL WASH | WALMART INC | 9e90c1c1-4dcd-106e-e053-2995a90afd15 | 2025-10-08 | Warnings | 8MDF5V39QO |
| GURUNANDA NASAL SALINE | NASAL WASH | GURUNANDA LLC | 2b4d78ae-b587-6dfe-e063-6394a90a8876 | 2025-10-08 | Warnings | 8MDF5V39QO |
| Mitochondria PRO | ARALIA QUINQUEFOLIA, ARNICA MONTANA, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ALPHA-KETOGLUTARICUM ACIDUM, ASCORBICUM ACIDUM, ALPHA-LIPOICUM ACIDUM, CALCAREA CARBONICA, CITRICUM ACIDUM, CUPRUM METALLICUM, CYSTEINUM, FERRUM METALLICUM, IODIUM, LEVOTHYROXINUM, MAGNESIUM GLUCONICUM DIHYDRICUM, MALICUM ACIDUM, MANGANUM ACETICUM, NADIDUM, NATRUM PYRUVICUM, NICOTINAMIDUM, PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, SELENIUM METALLICUM, SULPHUR, THIAMINUM HYDROCHLORICUM, UBIDECARENONUM, ZINCUM METALLICUM, | Energique, Inc. | 8c3e961d-bc33-40cd-a282-a4fe5aa3f0ad | 2025-10-06 | Warnings | XF417D3PSL |
| Kidnex IV | GINKGO BILOBA, ALPHA-KETOGLUTARICUM ACIDUM, CITRICUM ACIDUM, FUMARICUM ACIDUM, MALICUM ACIDUM, PYRUVIC ACID, SUCCINICUM ACIDUM, ARGENTUM METALLICUM, AURUM METALLICUM, CUPRUM METALLICUM, GERMANIUM SESQUIOXIDE, MERCURIUS VIVUS, NUX VOMICA, KIDNEY (SUIS), LYMPH NODE (SUIS), NAPHTHOCHINONUM, NATRUM OXALACETICUM, PHOSPHORUS, URINARY BLADDER (SUIS), ACONITICUM ACIDUM, CIS- | Energique, Inc. | 121eb51a-befe-47ea-85c6-d77e8c7e5864 | 2025-10-06 | Warnings | XF417D3PSL |
| Omeprazole and Sodium Bicarbonate | OMEPRAZOLE AND SODIUM BICARBONATE | Ajanta Pharma USA Inc. | cb657607-b038-47ee-b4e7-a5f419a14c33 | 2025-10-06 | Warnings, Adverse reactions | 8MDF5V39QO |
| Fentanyl Citrate | FENTANYL CITRATE | Fresenius Kabi USA, LLC | 0c10e465-4117-48ba-a454-23ccb7a3fcc7 | 2025-09-24 | Boxed warning, Warnings, Adverse reactions | MUN5LYG46H |
| Sodium Bicarbonate | SODIUM BICARBONATE | Fresenius Kabi USA, LLC | 0ab55004-bb63-436d-ad77-cd3796905370 | 2025-09-23 | Warnings, Adverse reactions | 8MDF5V39QO |
| Stomachin Antacid | MAGNESIUM CARBONATE AND SODIUM BICARBONATE | Chang Kuo Chou Pharmaceutical Co., Ltd. | 60fa0650-8785-4cb3-8f88-1a437296252f | 2025-09-19 | Warnings | 8MDF5V39QO |
| GAVILYTE-N | POLYETHYLENE GLYCOL-3350, SODIUM CHLORIDE, POTASSIUM CHLORIDE AND SODIUM BICARBONATE | Lupin Pharmaceuticals,Inc. | 27195187-75a3-431f-90d9-84da1b94e849 | 2025-09-10 | Warnings, Adverse reactions | 8MDF5V39QO |
| GaviLyte - C TM | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES WITH FLAVOR PACK | Lupin Pharmaceuticals,Inc. | a8b15625-ca7c-4d57-9f36-3ac2a6d13665 | 2025-09-10 | Warnings, Adverse reactions | 8MDF5V39QO |
| GAVILYTE G TM | POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES | Lupin Pharmaceuticals,Inc. | 3978822b-6473-4072-9f80-20ceb9bea355 | 2025-09-10 | Warnings, Adverse reactions | 8MDF5V39QO |
| omeprazole and sodium bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | Meijer Distribution Inc | bb7c1c5d-b915-42f5-a5a2-5f61b088028d | 2025-09-05 | Warnings | 8MDF5V39QO |
| Polyethylene Glycol 3350 and electrolytes - Unflavored | POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES - UNFLAVORED | Strides Pharma Science Limited | 48c741a9-9039-4fdb-a875-86d4ea968282 | 2025-09-05 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate 10 GR (650 MG) | SODIUM BICARBONATE | Advanced Rx LLC | 634e8d52-6d04-42f9-98f6-2634473b5dfd | 2025-09-01 | Warnings | 8MDF5V39QO |
| Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate and Potassium Chloride - Unflavored | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE - UNFLAVORED | Strides Pharma Science Limited | 37c111ec-5b62-42b9-bbb2-3b0c530e34c9 | 2025-09-01 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | ProPharma Distribution | 3d71b046-3e0b-054a-e063-6294a90a563a | 2025-08-28 | Warnings, Adverse reactions | 8MDF5V39QO |
| Osmitrol | MANNITOL | Baxter Healthcare Company | 0d914965-7001-45cb-ba51-d7c5964b05bc | 2025-08-26 | Warnings, Adverse reactions | 3OWL53L36A |
| Indigestion-Gas | CHAMOMILLA, ECHINACEA, IRIS VERSICOLOR, RUTA GRAVEOLENS, TARAXACUM OFFICINALE, ALOE, ANGELICA SINENSIS RADIX, ANTIMONIUM , ARGENTUM NITRICUM, ARNICA MONTANA, ARSENICUM ALBUM, BAPTISIA TINCTORIA, BISMUTHUM METALLICUM, BRYONIA, CINCHONA OFFICINALIS, GRAPHITES, HYDRASTIS CANADENSIS, IPECACUANHA, LACHESIS MUTUS, LYCOPODIUM CLAVATUM, MYRRHA, NATRUM CARBONICUM, NUX VOMICA, PHOSPHORUS, PULSATILLA, ZINGIBER OFFICINALE. | Newton Laboratories, Inc. | 9c1c1525-9752-275d-e053-2a95a90acf43 | 2025-08-20 | Warnings | 45P3261C7T |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.